Serial Number
98313180
Owner
National Resilience, Inc.Attorney
ROSALEEN H. CHOUFiling Date
Dec 13, 2023
SNAPAAV Trademark
Serial Number: 98313180
Trademark Classes
Owner Contact Info
3115 Merryfield Row, Suite 200
San Diego, CA 92121
Entity Type: 03
Legal Representation
Correspondence Address
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP
2040 Main Street, 14th Floor
Knobbe, Martens, Olson & Bear, LLP
Irvine, CA 92614
United States
Trademark Details
Filing Date
December 13, 2023
Registration Date
Not Registered
Published for Opposition
October 29, 2024
Goods & Services
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services in the field of biological treatment and bioproduction; design and development of biotechnology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, provision of information for research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services, namely, the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins